Shares of AbbVie Inc. ABBV slid 1.55% to $206.27 Tuesday, on what proved to be an all-around mixed trading session for the ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

The general mood among these heavyweight investors is divided, with 43% leaning bullish and 21% bearish. Among these notable ...

Below is a list of the 15 stocks in the S&P 500 with the highest operating profitability. The top five include Colgate-Palmolive Co. (CL), DaVita Inc. (DVA), Verisk Analytics Inc. (VRSK), AbbVie Inc. ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. META -2.04% Get Free Report is his top pick out of the Mag ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty ...

AbbVie isn’t just injecting Botox—it’s injecting confidence into portfolios with a dazzling 52-year dividend streak and a 3.2% yield. AbbVie reported $15.1 billion in Q4 2025 revenue, beating ...

We recently published a list of the 15 Best Dividend Aristocrat Stocks with Over 3% Yield. In this article, we are going to ...

Explore some of the top defensive stocks to buy and hold ahead of Donald Trump's Liberation Day tariffs next week ...